HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--May 4, 2006--Nymox Pharmaceutical Corporation (NASDAQ:NYMX - News) announced today that it has entered into a new distribution agreement with Alifax S.p.A., a leading Italian medical diagnostic company, for the marketing and sales of its NicAlert(TM) product in Italy. NicAlert(TM) provides a proven, easy-to-use, on-site means of determining an individual’s level of tobacco product use or exposure to second-hand smoke. The product gives a visual read-out of the level of tobacco use or exposure within minutes and requires no instruments to use.
